Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma

European Journal of Clinical Investigation

Volumn 38, Issue 8, 2008, Pages 571-577

  Beneduce, L ^a,b   Pesce, G ^b   Gallotta, A ^b   Zampieri, F ^b   Biasiolo, A ^c   Tono, N ^d   Boscato, N ^c   Gatta, A ^c   Pontisso, P ^c   Fassina, G ^b  

^a XEPTAGEN SpA   (Italy)

^b Xeptagen SpA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Des gamma carboxy prothrombin; Hepatocellular carcinoma; IgM immune complexes; Immune surveillance; Natural immunity

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

AGED; ALPHA-FETOPROTEINS; ANTIGEN-ANTIBODY COMPLEX; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN M; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; PROTHROMBIN; TUMOR MARKERS, BIOLOGICAL;

EID: 47649088931     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.01985.x     Document Type: Article

References (27)

1. Swann BJ, Smyth MJ. Immune surveillance of tumours. J Clin Invest 2007 117 : 1137 45.
2. Ehrlich P. About the current state of cancer research. Ned Tijdschr Geneeskd 1909 5 : 273 90.
3. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002 3 : 991 8.
4. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005 80 : S254 64.
5. Bhardwaj N. Harnessing the immune system to treat cancer. J Clin Invest 2007 117 : 1130 6.
6. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006 10 : 715 27.
7. Vollmers HP, Brandlein S. The 'early birds': natural IgM antibodies and immune surveillance. Histol Histopathol 2005 20 : 927 37.
8. Vollmers HP, Brandlein S. Natural IgM antibodies: from parias to parvenus. Histol Histopathol 2006 21 : 1355 36.
9. Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005 353 : 1224 35.
10. Nesterova M, Johnson N, Cheadle C, Cho-Chung YS. Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta 2006 1762 : 398 403.
11. Beneduce L, Prayer-Galletti T, Marcello Grimani Giustinian A, Gallotta A, Betto G, Pagano F et al. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients. Cancer Detect Prev 2007 31 : 402 7.
12. Castaldi F, Marino M, Beneduce L, Belluco C, De Marchi F, Mammano E et al. Detection of circulating CEA-IgM complexes in early stage (stage 1) colorectal cancer. Int J Biol Markers 2005 20 : 204 8.
13. Pontisso P, Calabrese F, Benvegnù L, Lise M, Belluco C, Ruvoletto MG et al. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 2004 90 : 833 7.
14. Beneduce L, Castaldi F, Marino M, Tono N, Gatta A, Pontisso P et al. Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes. Int J Biol Markers 2004 19 : 155 9.
15. Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L et al. Squamous cell carcinoma antigen-IgM complexes as novel biomarkers for hepatocellular carcinoma. Cancer 2005 103 : 2558 65.
16. Pontisso P, Quarta S, Caberlotto C, Beneduce L, Marino M, Bernardinello E et al. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma. Int J Cancer 2006 119 : 735 40.
17. Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Eng J Med 1984 310 : 1427 31.
18. Ono M, Ohta H, Ohhira M, Sekiya C, Namiki M. Measurement of immunoreactive prothrombin precursor and vitamin-K dependent gamma-carboxylation in human hepatocellular carcinoma tissues: decreased carboxylation of prothrombin precursor as a cause of des-gamma-carboxyprothrombin synthesis. Tumor Biol 1990 11 : 319 26.
19. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K et al. Serum levels of des-γ-carboxyprothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma. Cancer 2000 88 : 544 9.
20. Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ et al. Des-gamma carboxythrombin can differentiate hepatocellular carcinoma from non malignant chronic liver disease in American patients. Hepatology 2003 37 : 1114 21.
21. Volk ML, Hernandez JC, Su GL, Lok AS, Marrero JA. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers. A comparison of AFP, DCP, AFP-L3. Cancer Biomark 2007 3 : 79 87.
22. Toyoda H, Kumada T, Osaki Y, Oka H, Kudo M. Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma. Hepatol Res 2007 37 (Suppl. 2 S166 71.
23. Lacroix-Desmazes S, Kaveri SV, Mouthon L, Ayouba A, Malanchere E, Coutinho A et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Meth 1998 216 : 117 37.
24. Varambally S, Bar-Dayan Y, Bayry J, Lacroix-Desmazes S, Horn M, Sorel M et al. Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells. Int Immunol 2004 16 : 517 24.
25. Vollmers HP, Brandlein S. Natural antibodies and cancer. J Autoimmun 2007 29 : 295 302.
26. Schreiber RD. Cancer vaccines 2004 opening address: The molecular and cellular basis of cancer immunosurveillance and immunoediting. Cancer Immun 2005 5 (Suppl. 1 1 8.
27. Vollmers HP, Brandlein S. Natural IgM antibodies: The orphaned molecules in immune surveillance. Adv Drug Deliv Rev 2006 58 : 755 65.